MedPath

Vertanical GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Low Back Pain

Phase 3
Not yet recruiting
Conditions
Chronic Low Back Pain
Interventions
Other: Placebo
First Posted Date
2025-05-02
Last Posted Date
2025-05-02
Lead Sponsor
Vertanical GmbH
Target Recruit Count
700
Registration Number
NCT06956014

Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

Phase 2
Active, not recruiting
Conditions
Chronic Non-specific Low Back Pain
Interventions
Drug: Placebo
First Posted Date
2024-06-26
Last Posted Date
2025-05-20
Lead Sponsor
Vertanical GmbH
Target Recruit Count
652
Registration Number
NCT06475001
Locations
🇬🇧

St Pancras Clinical Research, London, United Kingdom

Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain

Phase 3
Completed
Conditions
Chronic Non-specific Low Back Pain
Interventions
Drug: Opioid therapy
First Posted Date
2022-11-09
Last Posted Date
2024-11-25
Lead Sponsor
Vertanical GmbH
Target Recruit Count
384
Registration Number
NCT05610813
Locations
🇩🇪

Medizinische Hochschule Hannover (MHH), Hannover, Germany

🇩🇪

Rheumazentrum Prof. Dr. med. Gunther Neeck, Bad Doberan, Germany

Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

Phase 3
Completed
Conditions
Chronic Non-specific Low Back Pain
Interventions
Other: Placebo
First Posted Date
2021-06-28
Last Posted Date
2024-04-08
Lead Sponsor
Vertanical GmbH
Target Recruit Count
820
Registration Number
NCT04940741
Locations
🇩🇪

Emovis GmbH, Berlin, Germany

Single and Multiple Dose Study of VER-01 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2021-06-18
Last Posted Date
2022-07-14
Lead Sponsor
Vertanical GmbH
Target Recruit Count
42
Registration Number
NCT04930809
Locations
🇦🇹

University of Medicine in Vienna - Department of Clinical Pharmacology, Vienna, Austria

Food Effect Study of VER-01 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2021-06-18
Last Posted Date
2022-11-28
Lead Sponsor
Vertanical GmbH
Target Recruit Count
18
Registration Number
NCT04930796
Locations
🇦🇹

University of Medicine in Vienna - Department of Clinical Pharmacology, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath